Page last updated: 2024-11-02

phenoxybenzamine and Hypokalemia

phenoxybenzamine has been researched along with Hypokalemia in 2 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lambotte, L1
Wilson, RJ1
Craig, GM1
Mills, IH1

Other Studies

2 other studies available for phenoxybenzamine and Hypokalemia

ArticleYear
[The role of the liver in post-insulin hypokalemia].
    Archives internationales de physiologie et de biochimie, 1965, Volume: 73, Issue:2

    Topics: Animals; Dogs; Epinephrine; Hepatic Veins; Hypokalemia; Insulin; Liver; Liver Circulation; Phenoxybe

1965
Metabolic studies in a patient with a phaeochromocytoma associated with hypokalaemia and hyperaldosteronism.
    The Journal of endocrinology, 1973, Volume: 56, Issue:1

    Topics: Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Blood Urea Nitrogen; Blood Volume; Creatinine;

1973